<!-- HTML_TAG_START -->NasdaqGS:BRKR Earnings and Revenue Growth December 30th 2024<!-- HTML_TAG_END -->
As an investor its worth striving to ensure your overall portfolio beats the market average. But the risk of stock picking is that you will likely buy under-performing companies. We regret to report that long term Bruker Corporation (NASDAQ:BRKR) shareholders have had that experience, with the share price dropping 28% in three years, versus a market return of about 24%. And more recent buyers are having a tough time too, with a drop of 21% in the last year. The falls have accelerated recently, with the share price down 13% in the last three months.
So let’s have a look and see if the longer term performance of the company has been in line with the underlying business’ progress.
View our latest analysis for Bruker
While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.
During the unfortunate three years of share price decline, Bruker actually saw its earnings per share (EPS) improve by 4.1% per year. Given the share price reaction, one might suspect that EPS is not a good guide to the business performance during the period (perhaps due to a one-off loss or gain). Or else the company was over-hyped in the past, and so its growth has disappointed.
After considering the numbers, we’d posit that the the market had higher expectations of EPS growth, three years back. Looking to other metrics might better explain the share price change.
With a rather small yield of just 0.3% we doubt that the stock’s share price is based on its dividend. We note that, in three years, revenue has actually grown at a 11% annual rate, so that doesn’t seem to be a reason to sell shares. It’s probably worth investigating Bruker further; while we may be missing something on this analysis, there might also be an opportunity.
You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).
It’s good to see that there was some significant insider buying in the last three months. That’s a positive. On the other hand, we think the revenue and earnings trends are much more meaningful measures of the business. So it makes a lot of sense to check out what analysts think Bruker will earn in the future (free profit forecasts).
While the broader market gained around 26% in the last year, Bruker shareholders lost 20% (even including dividends). However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. On the bright side, long term shareholders have made money, with a gain of 3% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. It’s always interesting to track share price performance over the longer term. But to understand Bruker better, we need to consider many other factors. For example, we’ve discovered 2 warning signs for Bruker (1 is potentially serious!) that you should be aware of before investing here.
